Prosthetic Joint Infection Recruiting Phase 4 Trials for Nafcillin (DB00607)

Also known as: Prosthetic joint infection

IndicationStatusPhase
DBCOND0042748 (Prosthetic Joint Infection)Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03426761Dalbavancin For The Treatment of Gram Positive Osteoarticular InfectionsTreatment